Literature DB >> 17603190

On the interaction of doxorubicin with oleate ions: fluorescence spectroscopy and liquid-liquid extraction study.

Emilie Munnier1, Frédéric Tewes, Simone Cohen-Jonathan, Claude Linassier, Laurence Douziech-Eyrolles, Hervé Marchais, Martin Soucé, Katel Hervé, Pierre Dubois, Igor Chourpa.   

Abstract

Increase of lipophilicity of cationic doxorubicin (DOX) by its association with a fatty acid ion is of interest for pharmaceutical formulations and could have an impact on the drug delivery into cancer cells. On the basis of spectroscopic analysis of intrinsic DOX fluorescence, this study provides an experimental evidence of DOX-oleate interactions as function of ion/drug molar ratio (R) and pH. An electrostatic attraction to oleates is dominant for the cationic form of DOX (pH 6.5) and a hydrophobic interaction is characteristic of the molecular form of DOX (pH 8.6). A high content of sodium oleate vesicles ([oleate]>/=0.2 mM, R>/=20) limits the electrostatic and hydrophobic interactions at pH 6.5 while favoring the hydrophobic interactions at pH 8.6. The influence of these interactions on the lipophilicity of the cationic form of DOX is analyzed by measuring the apparent partition coefficient (aqueous buffer pH 6.5/methylene chloride). The results show a lipophilicity gain for the cationic form of DOX in presence of 10 : 1 ion/drug molar ratio, while no lipophilicity increase is observed at 50 : 1 molar ratio.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17603190      PMCID: PMC4712348          DOI: 10.1248/cpb.55.1006

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  20 in total

1.  Synthesis and preliminary antitumor activity evaluation of a DHA and doxorubicin conjugate.

Authors:  Yuqiang Wang; Lianfa Li; Wei Jiang; Zhaoqi Yang; Zaijun Zhang
Journal:  Bioorg Med Chem Lett       Date:  2006-03-24       Impact factor: 2.823

2.  Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells.

Authors:  J A Menéndez; M del Mar Barbacid; S Montero; E Sevilla; E Escrich; M Solanas; H Cortés-Funes; R Colomer
Journal:  Eur J Cancer       Date:  2001-02       Impact factor: 9.162

Review 3.  Mechanism of multidrug resistance.

Authors:  G Bradley; P F Juranka; V Ling
Journal:  Biochim Biophys Acta       Date:  1988-08-03

4.  Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles. Circular dichroism study.

Authors:  L Gallois; M Fiallo; A Garnier-Suillerot
Journal:  Biochim Biophys Acta       Date:  1998-03-06

5.  Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods.

Authors:  F Tewes; E Munnier; B Antoon; L Ngaboni Okassa; S Cohen-Jonathan; H Marchais; L Douziech-Eyrolles; M Soucé; P Dubois; I Chourpa
Journal:  Eur J Pharm Biopharm       Date:  2007-02-28       Impact factor: 5.571

6.  Determination of phenolic ionization constants of anthracyclines with modified substitution pattern of anthraquinone chromophore.

Authors:  G Razzano; V Rizzo; A Vigevani
Journal:  Farmaco       Date:  1990-02

7.  Sequence specificity of formaldehyde-mediated covalent binding of anthracycline derivatives to DNA.

Authors:  Agata Szulawska; Marek Gniazdowski; Malgorzata Czyz
Journal:  Biochem Pharmacol       Date:  2005-01-01       Impact factor: 5.858

8.  Thermodynamics of demicellization of mixed micelles composed of sodium oleate and bile salts.

Authors:  Annegret Hildebrand; Patrick Garidel; Reinhard Neubert; Alfred Blume
Journal:  Langmuir       Date:  2004-01-20       Impact factor: 3.882

9.  Interactions of chlorophyllin with acridine orange, quinacrine mustard and doxorubicin analyzed by light absorption and fluorescence spectroscopy.

Authors:  Monika Pietrzak; Zbigniew Wieczorek; Alicja Stachelska; Zbigniew Darzynkiewicz
Journal:  Biophys Chem       Date:  2003-05-01       Impact factor: 2.352

10.  Deciphering the fluorescence signature of daunomycin and doxorubicin.

Authors:  K K Karukstis; E H Thompson; J A Whiles; R J Rosenfeld
Journal:  Biophys Chem       Date:  1998-07-27       Impact factor: 2.352

View more
  3 in total

1.  Location of stimuli-responsive peptide sequences within silk-elastinlike protein-based polymers affects nanostructure assembly and drug-polymer interactions.

Authors:  Kyle J Isaacson; M Martin Jensen; Douglas B Steinhauff; James E Kirklow; Raziye Mohammadpour; Jason W Grunberger; Joseph Cappello; Hamidreza Ghandehari
Journal:  J Drug Target       Date:  2020-04-29       Impact factor: 5.121

2.  Bifunctional folic-conjugated aspartic-modified Fe3O4 nanocarriers for efficient targeted anticancer drug delivery.

Authors:  Munawar Khalil; Ely Arina Haq; Astari Dwiranti; Eka Sunarwidhi Prasedya; Yoshitaka Kitamoto
Journal:  RSC Adv       Date:  2022-02-09       Impact factor: 3.361

3.  Magnetic Driven Nanocarriers for pH-Responsive Doxorubicin Release in Cancer Therapy.

Authors:  João Nogueira; Sofia F Soares; Carlos O Amorim; João S Amaral; Cláudia Silva; Fátima Martel; Tito Trindade; Ana L Daniel-da-Silva
Journal:  Molecules       Date:  2020-01-14       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.